HCPCS Code Descriptor:
Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
42367-0521-25, 42367-0520-25, 60505-6228-00
Route of Administration:
BELRAPZO is an Oncology drug manufactured by Eagle Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9036 is aligned to the drug BELRAPZO.
Belrapzo is used to treat certain types of cancer and belongs to group of drugs known as alkylating agents. Belrapzo is manufactured by both Eagle Pharmaceuticals and Baxter Healthcare. There are two J Codes for Belrapzo: J9036 and J9306. Patient assistance programs for this medication can be found through Eagle Pharmaceuticals at the Eagle Can: Care & Access Network.